Anzeige
Mehr »
Login
Dienstag, 11.02.2025 Börsentäglich über 12.000 News von 685 internationalen Medien
US-Biotech-Firma sorgt für Furore - steckt hier die Zukunft der Krebsheilung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DBDW | ISIN: GB00BMD0WG01 | Ticker-Symbol: T61
Stuttgart
28.08.24
08:08 Uhr
0,002 Euro
0,000
0,00 %
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
CHALLENGERX PLC Chart 1 Jahr
5-Tage-Chart
CHALLENGERX PLC 5-Tage-Chart
PR Newswire
206 Leser
Artikel bewerten:
(1)

ChallengerX Plc - Management accounts for the quarters ended 31 December and 30 September 2024

Finanznachrichten News

ChallengerX Plc - Management accounts for the quarters ended 31 December and 30 September 2024

PR Newswire

LONDON, United Kingdom, January 31

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

31 January 2025

ChallengerX plc
("ChallengerX", "CX"orthe"Company")

Management accounts for the quarters ended31 December 2024 and 30 September 2024

ChallengerX (AQUIS: CXS) announces its unaudited management accounts reports for the quarters ended 31 December 2024 and 30 September 2024.

For further information, please contact:

ChallengerXplc

John May, Chairman

jmay@city-westminster.com

Stuart Adam, CFO

sjadam@city-westminster.com

DirectorsStatement

Introduction

ChallengerX plc (the "Company" or "ChallengerX") is quoted on the Aquis Stock Exchange ("AQSE") Growth Market. The Company was incorporated on 7 June 2021 and its shares were admitted to trading on 23 December 2021. Trading in the Company's ordinary shares on AQSE was suspended on 6 June 2024. The Company is aware of its continuing obligations under the AQSE rules.

Activitiesduringtheperiods

The Company was in negotiations to complete a significant transaction for the Company; it was also reviewing other products to add to its core business. The Company's aim is to enhance its position and seek to restore its shares to trading as soon as possible.

Outlook

On 8 January the Company announced it had raised a total of £120,000 through the issuance of a Convertible Loan Note. The Loan will be automatically converted into 120,000,000 ordinary shares of £0.001 each in the Company upon the relisting of ChallengerX Shares on the Aquis Stock Exchange.

On 20 January the Company further announced it is in active negotiations with the owners of Nyce International Limited and Virya VC Limited, with the aim to acquire their entire issued share capital. In addition, as part of this transaction, the Company announced the intention to enter into a licensing agreement in relation to an instance of Reelsoft AB's Vision RGS (Remote Gaming Server) and Game Aggregation Platform (together, the "Potential Acquisitions").

The Company is at an advanced stage of its legal and financial due diligence process and negotiation of the share purchase agreements and licensing agreements. A significant part of the costs associated with this process have been included in expenditure to 31 December 2024.

The Board is also negotiating certain new board appointments and working alongside an Aquis Corporate Adviser to conduct a review of the potential candidates' experience and background as well as of the enlarged group's suitability, following completion of the Potential Acquisitions and readmission to trading on the Aquis Stock Exchange.

It is not expected that the Potential Acquisitions would constitute a Reverse Takeover under Rule 3.6 of the Access Rulebook.

The Potential Acquisitions are subject to a number of conditions, including the lifting of the suspension to trading of ChallengerX Shares by Aquis Stock Exchange, the issue and admission of the new Ordinary Shares to trading, and completion of a fundraise in a sufficient amount to satisfy the enlarged group's working capital requirement.

The completion of the Potential Acquisitions and relisting of ChallengerX Shares on the Aquis Stock Exchange cannot be guaranteed.

John May

Chairman

Statement of Comprehensive Income forthe quarters ended 31 December 2024 and 30 September 2024

31 December

2024

30 September

2024

£'000

£'000

Revenue

-

-

Administrative expenses

(121)

(46)

Operatingloss

(121)

(46)

Lossbefore tax

(121)

(46)

Taxation

-

-

Lossfortheperiod

(121)

(46)

Totalcomprehensiveloss

(121)

(46)

(Loss)pershare(pence)fromcontinuingoperationsattributableto

ownersoftheCompany-Basic and diluted earnings per share

(0.028)

(0.011)

Statement of Financial Position as at quarters ended 31 December 2024 and 30 September 2024

31 December

2024

£'000

30 September

2024

(restated)

£'000

Intangible assets

Software Licence

-

-

Currentassets

Trade and other receivables

16

4

Cash and cash equivalents

103

1

Totalcurrentassets

119

5

Totalassets

119

5

Currentliabilities

Trade and other payables

473

238

Totalcurrentliabilities

473

238

Netassets

(354)

(233)

Capitalandreserves

Share capital:

- Issued

- Treasury

432

1

432

1

Total share capital

433

433

Share premium

1,786

1,786

Retained earnings

(2,573)

(2,452)

Totalequity

(354)

(233)

StatementofChangesinEquity

Forthequarters ended

31 December 2024 and 30 September 2024

Share capital

Share premium

Retained earnings

Total

£'000

£'000

£'000

£'000

As at 30 June 2024 (restated)

433

1,786

(2,406)

(187)

Issue of share capital

-

-

-

-

Loss for the quarter ended 30 September 2024

-

-

(46)

(46)

TotalComprehensiveIncome

-

-

(46)

(46)

Asat30 September 2024

433

1,786

(2,452)

(233)

Issue of share capital

-

-

-

-

Loss for the quarter ended 31 December 2024

-

-

(121)

(121)

TotalComprehensiveIncome

-

-

(121)

(121)

Asat31 December 2024

433

1,786

(2,573)

(354)

StatementofCashFlows

Forthe quarters ended 31 December 2024

and 30 September 2024

31 December 2024

30 September2024

£'000

£'000

Cashfromoperatingactivities

Loss before tax

(121)

(46)

Adjustments for:

(Increase)/decrease in trade and other receivables

(12)

3

Increase /(decrease) in trade and other payables

115

42

Netcash (used)inoperatingactivities

(18)

(1)

Cash flows from financing activities

Issue of share capital

-

-

Adjustment to share premium

-

-

Loan received

120

-

Netcashfromfinancingactivities

120

-

Netcashflowforthe period

102

(1)

Cash and cash equivalents at beginning of period

1

2

Cashandcashequivalentsatendofperiod

103

1

Netchangeincashandcashequivalents

103

(1)

Cashandcashequivalentscomprise:

Cash at bank and in hand

103

1

103

1

Notestothefinancialstatements

  1. General information

ChallengerX plc is a public limited company limited by shares and was incorporated in England on 7 June 2021 with company number 13440398. Its registered office is 16 Great Queen Street, London, WC2B 5DG.

The Company's shares are currently suspended from trading on the Aquis Stock Exchange Growth Market under symbol CXS and ISIN number GB00BMD0WG01.

The Company was first incorporated on 7 June 2021.

The information for periods ended 31 December 2024 and 30 September 2024 are unaudited.

  1. Basis of Preparation

The quarterly management accounts of ChallengerX plc have been prepared in compliance with United Kingdom Accounting Standards, including Financial Reporting Standard 102, "The Financial Reporting Standard applicable in the United Kingdom and the Republic of Ireland" ("FRS 102") and the Companies Act 2006.

These management accounts are prepared on a going concern basis, under the historical cost convention.

The financial statements are presented in Pounds Sterling, which is the Company's presentation and functional

currency.

The preparation of the financial statements requires the use of certain critical accounting estimates. It also requires management to exercise its judgment in the process of applying the Company's accounting policies.

The financial statements have been prepared on the historical cost basis and are presented in £'000 unless

otherwise stated.

  1. Going Concern

As at 31 December 2024, the Company had cash of £103,341. The Company has limited operating cash flow and is dependent on the performance of its trading and its cash balances for its working capital requirements. As at the date of this report, the Company had approximately £78,327 cash at bank.

In making their assessment of going concern, the Directors, having made due and careful enquiry, are of the opinion that the Company will have access to adequate working capital to meet its obligations for the period of at least 12 months from the date these management accounts are authorized for issue. The Directors, have discussed the Company's position with its investors and potential investors and believes it will secure the funding required to pursue its objectives.

The Directors believe in the Company's potential. However, the success of securing funding has been identified as a material uncertainty which may cast significant doubt over the going concern assessment. Whilst acknowledging this uncertainty, based upon the expectation of completing a successful fundraising in the near future, and the continued support of its investors, the Directors consider it appropriate to continue to prepare the financial statements on a going concern basis.

  1. Earnings per share

31 December 2024

30 September 2024

Earnings

£'000

£'000

Loss for the quarters ended

(121)

(46)

Numberofshares

Number of shares for the purposes of basic and diluted earnings per share

432,580,556

432,580,556

Earnings per share (pence)

(0.028)

(0.011)




© 2025 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.